Caris Life Sciences
Pioneer in precision medicine.
Irving, Texas, United States
Precision oncology platform with IPO in 2025
How We Help
Problem Statement
Caris Life Sciences addresses the challenge of providing individualized patient diagnoses and treatment by moving healthcare from intuitive to empirical medicine, utilizing precise molecular insights to improve patient outcomes.
Core Technology
Comprehensive molecular profiling, including Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) of both tissue and blood samples, advanced Artificial Intelligence (AI) and machine learning algorithms (e.g., Caris CODEai, Caris GPSai), proprietary aptamer-based proteomic profiling platforms (ADAPT), and whole slide imaging.
Key Differentiators
Comprehensive Molecular Profiling; Massive Clinico-Genomic Database; Advanced AI and Machine Learning; Focus on Precision Medicine; Innovative Solutions; Patient-Centric Approach; Strategic Partnerships.
Clinical Focus
Precision medicine, primarily in oncology (cancer detection, diagnosis, monitoring, and therapy selection), expanding to cardiology, neurology, metabolic conditions, hematologic malignancies, and other chronic diseases.
Target Customers
Physicians, Patients, Pharmaceutical companies, Research organizations, Biopharma companies.
Product Stage
GA/Mature
Company Info
- Business Model
- B2B, Services, Partnerships, Licensing. The company provides comprehensive molecular profiling services, R&D services for biopharma companies, and generates revenue through collaborations and licensing agreements with pharmaceutical companies and research organizations.
- Founded
- 1996
- Total Funding
- 1,860,000,000
- Website
- www.carislifesciences.com
Categories
Disease Areas
Technologies
MedStartr Index Score
?What do you think of Caris Life Sciences?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.